Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A focused evaluation asks which retirement index fund—Total Market or Sp 500—better fits long-term goals, balancing fees, risk, and growth potential.
28,526 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Bitcoin retraced after a volatile stretch, pushing traders to rethink income-focused strategies. This piece breaks do...
SpaceX's record IPO ignited a heated spacex wall street debating about AI spending and market risk. This piece breaks...
Hynix’s move onto the Nasdaq marks a watershed moment for foreign listings in the U.S. tech space. This article break...
Investors chasing high-tech breakthroughs often bet on early-stage companies like Rigetti. This article breaks down w...
Oklo faced a sharp pullback in early 2026 as sector bets cooled and financing moves pressured shares. This guide brea...
Rivian unveils the R2 with a sub-$45k price target and near-term shipments, while Lucid battles cash burn and no 2026...
A majority of Americans fear AI-driven job losses will push the cost and effort of buying a home out of reach, accord...
NuScale Power faced a sharp February sell-off as project delays, funding needs, and analyst downgrades weighed on the...
A seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
SoundHound AI reported mixed results, sparking a notable stock drop. This guide breaks down why the stock fell, what ...
Urban air mobility could redefine commuting, but investing in Joby Aviation requires weighing regulation, costs, and ...